Transmural Systems
Transmural has successfully leveraged over $36 million in SBIR funding to advance development of new innovative medical devices that address unmet…
AstraZeneca
EGC supported AstraZeneca in securing over $11 million in NIH funding to advance its first-in-class therapeutic candidate into a Phase 2 clinical…
AgroSpheres
AgroSpheres secured $2.3 million in federal funding, leading to $45 million in investor funding to further commercialization of
WinSanTor
Over $40M in Funding Propels Neuropathy Therapy to Phase 3 Clinical Trials...
Kepley Biosystems
Kepley Biosystems Thrives with EGC’s Expert Accounting, Advancing Sustainable Technologies Since 2015.
InnAVasc
InnAVasc Medical acquired by W. L. Gore & Associates following $2M in NIH funding to continue developing their novel vascular graft
Lightengale
Lightengale's novel intravenous tubing system recognized by FDA, NIH, and NSF for...
Bezwada Biomedical
Bezwada Biomedical has secured $1.6 M from NSF to advance their bioabsorbable surgical tissue adhesive, TissuBond™.
Scioto Biosciences
Scioto Biosciences secures >$2.5M in NIH funding, attracting a $26.5M Series B investment...
Dignify Therapeutics
Dignify Therapeutics has secured >$20M in funding to assist in the development of their therapeutics for people with spinal cord injuries.
Ascent Integrated Tech
Securing over $2.8M in funding, Ascent Integrated Tech developed a system to monitor firefighters' health and environment.
Laser Thermal
Laser Thermal has secured $7.5 million SBIR awards from (DoW and NIST to advance precision thermal metrology
Accelerating development of innovative technologies
EGC’s extraordinary team of scientists and accountants are ready to secure and manage non-dilutive funding to support your scientific innovations. Contact us to learn more.